Archives: Speakers

Eun-Jihn Roh, R.Ph, MS, is a clinical development executive with more than 20 years of experience across global pharmaceutical companies, CROs, and biotechnology companies, including over 15 years in oncology drug development. She currently serves as Chief Development Officer at Nex-I and Selecxine, where she leads global clinical and regulatory strategy for early-stage oncology programs. Her experience spans first-in-human through pivotal studies, FDA and MFDS interactions, clinical trial design, CRO oversight, business development, and global study execution.

Sunee Chuasuwan is the Head of Clinical Operations and Trial Management at the International Vaccine Institute (IVI). Her background is in nursing, with a master’s degree in industrial and organizational psychology.
She has led clinical operations and trial management activities across global clinical trials at IVI since 2020. With more than 25 years of experience in the pharmaceutical, CRO, and non-profit sectors, she has extensive expertise in clinical operations, project management, process improvement, and team leadership. She has played a key role in advancing vaccine trial sites for clinical trials conducted globally, including LMICs, for various vaccine program developments such as Cholera, COVID-19, Chikungunya, Dengue, Hepatitis B and E, HPV, Varicella, and so on.

2014 건국대학교 수의학과 졸업/ DVM License

2017-2020 Celltrion Clinical Operation/ Budget & Contract management

2020-2025 SK Bioscience Clinical Operation/CRA, CPM, Clinical Strategy/Medical Writer

2025 – Current Eli Lilly Investigator Engagement – Clinical Research Lead

Sooyoung Kim is a Clinical Research Lead at Eli Lilly, responsible for leading the initiation and operational execution of clinical trials for Lilly molecules. His work focuses on country feasibility, site selection, patient enrollment, and investigator engagement. He has over 10 years of experience in the pharmaceutical industry and brings deep expertise in clinical operations, spanning roles at Celltrion, SK Bioscience and Eli Lilly. He holds a Doctor of Veterinary Medicine degree and is a licensed veterinarian.

Hyojin Park, Ph.D., is a thought leader in Korea at GlobalData, where he leads consulting and data solution work for pharmaceutical, biotech, and government clients. He previously spent four years at Clarivate on due diligence, repositioning, and competitive intelligence projects, and was an author of the Drugs to Watch series. He holds a Ph.D. in Medical Science from Yonsei University College of Medicine and has been a regular speaker on global R&D and investment trends for over 8 years.

Casey Ustick is a Therapeutic Strategy Lead for Metabolic Diseases at Worldwide Clinical Trials, where he provides scientific, operational, and strategic leadership for clinical development programs across obesity, diabetes, metabolic dysfunction-associated steatohepatitis (MASH), and related cardiometabolic disorders.

Matthew Laurent is the Head of Digital Solutions at KION Financial Services globally and a seasoned business executive with more than 20 years of experience leading large-scale business and digital transformations. Throughout his career, he has been responsible for modernizing business-critical systems, driving enterprise-wide transformation programs, and delivering complex business and technology change across international organizations.

Drawing on extensive experience in core platform replacement, system harmonization, and operational transformation, Matthew brings firsthand insights into the challenges of preserving business continuity while transforming mission-critical technology landscapes. His expertise spans business operations, enterprise architecture, digital transformation, IT strategy, process optimization, and large-scale data migration initiatives.

At KION, he continues to shape the organization’s technology and transformation agenda, focusing on enabling business growth through modern, scalable, and resilient digital platforms.

Rich Price is Head of Business Development at Cox Automotive Europe, working across the automotive ecosystem to develop strategic partnerships and drive growth with some of the industry’s leading retailer groups and OEMs.

Drawing on his experience working closely with retailers, manufacturers and partners across the sector, Rich brings a commercial, real-world perspective on the future of automotive retail, digital transformation and how businesses can deliver sustainable growth in a rapidly changing market.